Investing Ideas
/
German Pharmaceuticals & Biotech High Return On Equity, Low Debt

German Pharmaceuticals & Biotech High Return On Equity, Low Debt

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

0 new

Stocks with a return on equity of over 30% and a debt to equity ratio below 1.

1 companies

2invest

Market Cap: €63.4m

An investment company, acquires, holds, manages, and sells investments in corporations and partnerships primarily in the biotechnology, life science, IT sectors, and natural resources sectors in Germany and internationally.

2INV

€11.50

-1.7%